Mary Ann Liebert, Inc., The Leading Publisher in Biotechnology
Oligonucleotides - Join the Oligonucleotide Therapeutics Society & receive the journal as a membership benefit
ISSN 1545-4576 - Published Quarterly
Subscribe
Oligonucleotides is a quarterly peer-reviewed journal on human-made substances such as oligonucleotides, RNA, and ribozymes and their effects on gene expression at the RNA and DNA levels both in vitro and in vivo. A forum for basic researchers in molecular biology, cell biology, nucleic acid chemistry, pharmacology, and applied therapeutics for the purpose of developing new concepts and experimental approaches to help understand and modulate gene activity.
The official journal of the Oligonucleotide Therapeutics Society, Inc.
Join OTS or Renew Your Membership in OTS and receive electronic access to all available papers online, as well as four print issues per year.
Latest Impact Factor* is 2.086
*Journal Citation Reports® 2008, published by Thomson Reuters
SubscribeIndexed/abstracted in:
MEDLINE; Current Contents®/Life Sciences; EMBASE/Excerpta Medica; Science Citation Index Expanded; Science Citation Index®; BIOSIS Previews; SIIC Databases; Biotechnology Citation Index®; Biological Abstracts; EMBiology; Scopus
